A <i>Salmonella</i> Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination
Vi-polysaccharide conjugate vaccines are efficacious against typhoid fever in children living in endemic settings, their recent deployment is a promising step in the control of typhoid fever. However, there is currently no accepted correlate of protection. IgG and IgA antibodies generated in respons...
Main Authors: | Elizabeth Jones, Celina Jin, Lisa Stockdale, Christina Dold, Andrew J. Pollard, Jennifer Hill |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/7/1394 |
Similar Items
-
Typhoid vaccines. Historical aspects of typhoid vaccine development, and currently available products
by: M. V. Abramtseva, et al.
Published: (2021-07-01) -
A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicity
by: Sukamto Koesnoe, et al.
Published: (2024-02-01) -
Cost-effectiveness analysis of typhoid vaccination in Lao PDR
by: Mick Soukavong, et al.
Published: (2023-11-01) -
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
by: Megan E Carey, et al.
Published: (2023-09-01) -
IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model
by: Lindsay C. Dahora, et al.
Published: (2019-11-01)